News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
李氏大藥廠(00950.HK)合成表面活化劑項目獲蓋茨基金會批出財務資金
李氏大藥廠(00950.HK)公布，將獲得蓋茨基金會的財務資金，以支持集團的合成表面活化劑項目。此獲資助項目的短期目標為成功完成研究及開發活性藥物成分(API)及製劑，以及該藥物的製造過程。最終目標為以可負擔的價格將此款救命藥物引進中低收入國家，特別是為幫助患上呼吸窘迫症候群的早產嬰兒。(sl/da)~阿思達克財經新聞網址: www.aastocks.com
Reset
Send
The window will close in 5 seconds
李氏大藥廠(00950.HK)合成表面活化劑項目獲蓋茨基金會批出財務資金
Close
Recommend
2
Positive
1
Negative
1
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

李氏大藥廠(00950.HK)  -0.030 (-2.752%)   公布，將獲得蓋茨基金會的財務資金，以支持集團的合成表面活化劑項目。

此獲資助項目的短期目標為成功完成研究及開發活性藥物成分(API)及製劑，以及該藥物的製造過程。最終目標為以可負擔的價格將此款救命藥物引進中低收入國家，特別是為幫助患上呼吸窘迫症候群的早產嬰兒。(sl/da)(HK stocks quote is delayed for at least 15 mins.)

Switch to Auto-Translated Version
AASTOCKS新聞
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.